Mechanism Underlying a Proteasome Inhibitor, Lactacystin-Induced Apoptosis on SCC25 Human Tongue Squamous Cell Carcinoma Cells |
Baek, Chul-Jung
(Dept. of Oral Anatomy, School of Dentistry, Pusan National University)
Kim, Gyoo-Cheon (Dept. of Oral Anatomy, School of Dentistry, Pusan National University) Kim, In-Ryoung (Dept. of Oral Anatomy, School of Dentistry, Pusan National University) Lee, Seung-Eun (Dept. of Oral Anatomy, School of Dentistry, Pusan National University) Kwak, Hyun-Ho (Dept. of Oral Anatomy, School of Dentistry, Pusan National University) Park, Bong-Soo (Dept. of Oral Anatomy, School of Dentistry, Pusan National University) Tae, Il-Ho (Dept. of Oral Medicine, School of Dentistry, Pusan National University) Ko, Myung-Yun (Dept. of Oral Medicine, School of Dentistry, Pusan National University) Ahn, Yong-Woo (Dept. of Oral Medicine, School of Dentistry, Pusan National University) |
1 | Green DR and Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-1312 DOI PUBMED ScienceOn |
2 | Orlowski RZ. The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 1999;6:303-313 DOI PUBMED ScienceOn |
3 | Drexler HC. Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci USA 1997;94:855-860 DOI ScienceOn |
4 | Takezawa J, Ishimi Y, Yamada K. Proteasome inhibitors remarkably prevent translesion replication in cancer cells but not normal cells. Cancer Sci 2008;99: 863-871 DOI ScienceOn |
5 | Grimm LM, Goldberg AL, Poirier GG, Schwartz LM, Osborne BA. Proteasome play an essential role in thymocyte apoptosis. EMBO J 1996;15:3845-3852 PUBMED |
6 | Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997;18:44-51 DOI ScienceOn |
7 | Wagenknecht B, Hermission M, Groscurth P, Liston P, Krammer PH, Weller M. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J Neurochem 2000;75:2288-2297 DOI ScienceOn |
8 | Marshansky V, Wang X, Bertrand R et al. Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells. J Immunol 2001;166:3130-3142 DOI PUBMED |
9 | Li P, Nijhawan D, Budihardjo I et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-489 DOI ScienceOn |
10 | Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW. Three-dimensional structure of the apoptosome: Implications for assembly, procaspase-9 binding, and activation. Mol Cell 2002;9:423-432 DOI ScienceOn |
11 | Thornberry NA, Rosen A, Nicholson DW. Control of apoptosis by proteases. Adv In Pharmacol 1997;41: 155-177 DOI |
12 | Hunter JJ, Parslow TG. A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J Biol Chem 1996;271:8521-8524 DOI ScienceOn |
13 | Meriin AB, Gabai VL, Yaglom J, Shifrin VI, Sherman MY. Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis. J Biol Chem 1998;273:6373-6379 DOI ScienceOn |
14 | An WG, Hwang SG, Trepel JB, Blagosklonny MV. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition. Leukemia 2000;14:1276-1283 DOI ScienceOn |
15 | Kim JH, Bae HR, Park BS et al. Early mitochondrial hyperpolarization and intracellular alkalinization in lactacystin-induced apoptosis of retinal pigment epithelial cells. J Pharmacol Exp Ther 2003;305: 474-481 DOI ScienceOn |
16 | Elledge S, Harper W. Cdk inhibitors: on the threshold of checkpoints and development. Curr Op Cell Biol 1994;6:847–852 DOI PUBMED ScienceOn |
17 | Dauglas E, Susin SA, Zamzami N et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 2000;14:729-739 DOI |
18 | Thornberry NA, Lazebnik Y. Caspase: Enemies within. Science 1998;28:1312-1316 PUBMED |
19 | Brouckaert G, Kalai M, Saelens X, Vandenabeele P. Apoptotic Pathways and Their Regulation. In: Los, M., Gibson, S.B. (Eds.), Apoptotic Pathways as Target for Novel Therapies in Cancer and Other Diseases. New York. 2005, Springer Academic Press |
20 | Shinohara K, Tomioka M, Nakano H, Tone S, Ito H, Kawashima S. Apoptosis induction resulting from proteasome inhibition. Biochem J 1996;317:385-388 DOI PUBMED |
21 | Adams J. Development of the proteasome inhibitor PS-341. Oncologist 2002;7:9-16 PUBMED |
22 | Inoue T, Shiraki K, Fuke H et al. Proteasome inhibition sensitizes hepatocellular carcinoma cells to TRAIL by suppressing caspase inhibitors and AKT pathway. Anticancer Drugs. 2006;17:261-268 DOI ScienceOn |
23 | Pavletich NP. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol. 1999;287: 821-828 DOI PUBMED ScienceOn |
24 | Kudo Y, Takata T, Ogawa I et al. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells. Clin Cancer Res 2000;6:916-923 |
25 | Zou H, Li Y, Liu X, Wang, X. An APAF-1, cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999;274:11549–11556 DOI PUBMED ScienceOn |
26 | Cheng AC, Jian CB, Huang YT, Lai CS, Hsu PC, Pan MH. Induction of apoptosis by Uncaria tomentosa through reactive oxygen species production, cytochrome c release, and caspases activation in human leukemia cells. Food Chem Toxicol 2007;45:2206-2218 DOI ScienceOn |
27 | Pagano M, Tam SW, Theodoras AM et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995;269:682–685 DOI PUBMED |
28 | Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL. Inhibition of proteasome activities and subunit specific-amino terminal threonine modification by lactocystin. Science 1995;268:726–731 DOI PUBMED |
29 | Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell 1991;65:1097-1098 DOI PUBMED ScienceOn |
30 | Drexler HC, Risau W, Konerding MA. Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells. FASEB J 2000;14:65-77 DOI |
31 | Ohta K, Yamashita N. Apoptosis of eosinophils and lymphocytes in allergic inflammation. J Allergy Clin Immunol 1999;104:14-21 DOI ScienceOn |
32 | Pasquini LA, Besio Moreno M, Adamo AM, Pasquini JM, Soto EF. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells. J Neurosci Res. Mar 2000;59:601-611 DOI ScienceOn |
33 | Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993;341:1251-1254 DOI ScienceOn |
34 | Orlowski RZ, Eswara JR, Lafond-Walker A, Grever MR, Orlowski M, Dang CV. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor. Cancer Res 1998;58:4342-4348 PUBMED |
35 | Shen J, Huang C, Jiang L et al. Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines. Biochem Pharmacol 2007;73: 1901-1909 DOI ScienceOn |
36 | Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett 2004;149:19-23 DOI PUBMED ScienceOn |
37 | Meng L, Kwok BH, Sin N, Crews CM. Eponemycin exerts its antitumor effect through the inhibition of proteasome function. Cancer Res 1999;59:2798-2801 PUBMED |
38 | Lin ZP, Boller YC, Amer SM et al. Prevention of brefeldin A- induced resistance to teniposide by the proteasome inhibitor MG-132: involvement of NF-kappaB activation in drug resistance. Cancer Res 1998;58:3059-3069 PUBMED |
39 | Delic J, Masdehors P, Omura S et al. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radio-resistant human chronic lymphocytic leukemia lymphocytes to TNF-alphainitiated apoptosis. Br J Cancer 1998;77:1103-1107 DOI PUBMED ScienceOn |
40 | Susin SA, Lorenzo HK, Zamzami N et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441-446 DOI ScienceOn |
41 | Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999;13:1899-1911 DOI ScienceOn |
42 | Barczyk K, Kreuter M, Pryjma J et al. Serum cytochrome c indicates in vivo-apoptosis and it can serve as a prognostic marker during cancer therapy. In. J Cancer 2005;114:167–173 |
43 | Narita M, Shimizu S, Ito T et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria.Proc Natl Acad Sci U S A. 1998;95:14681-14686 DOI ScienceOn |
44 | Li B, Dou QP. Bax degradation by the ubiquitin/ proteasome-dependent pathway: Involvement in tumor survival and progression. Pro Natl Acad Sci USA 2000;97:3850-3855 DOI ScienceOn |
45 | Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68: 251-306 DOI PUBMED |
46 | Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-776 DOI PUBMED ScienceOn |
47 | Porter AG. Protein translocation in apoptosis. Trends Cell Biol 1999;9:394-401 DOI PUBMED ScienceOn |
48 | Adams J, Palombella VJ, Sausville EA et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 1999;59: 2615-2622 PUBMED |